{
    "ticker": "PLRX",
    "name": "Pulse Biosciences, Inc.",
    "description": "Pulse Biosciences, Inc. is a clinical-stage medical technology company focused on developing and commercializing its proprietary CellFX System, which utilizes a novel technology known as Nano-Pulse Stimulation (NPS). Founded in 2016 and headquartered in Hayward, California, Pulse Biosciences aims to revolutionize the treatment of various dermatological and oncological conditions through its innovative, non-invasive approach. The CellFX System is designed to selectively target and treat diseased cells while preserving surrounding healthy tissue, making it an attractive alternative to traditional surgical and ablative procedures. The company is currently focused on applications in dermatology, including the treatment of sebaceous hyperplasia, warts, and other skin lesions, as well as potential future applications in oncology and other therapeutic areas. Pulse Biosciences is committed to advancing its technology through rigorous clinical trials and regulatory approval processes, with the goal of improving patient outcomes and enhancing the overall standard of care. As the demand for minimally invasive treatment options continues to grow, Pulse Biosciences is well-positioned to become a leader in the medical technology space.",
    "industry": [
        "Medical Technology",
        "Healthcare"
    ],
    "headquarters": "Hayward, California, USA",
    "founded": "2016",
    "website": "https://www.pulsebiosciences.com",
    "ceo": "Darrin Uecker",
    "social_media": {
        "twitter": "https://twitter.com/PulseBiosci",
        "linkedin": "https://www.linkedin.com/company/pulse-biosciences/"
    },
    "investor_relations": "https://www.pulsebiosciences.com/investors",
    "key_executives": [
        {
            "name": "Darrin Uecker",
            "position": "CEO"
        },
        {
            "name": "Steven S. M. Ritchie",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Medical Devices",
            "products": [
                "CellFX System"
            ]
        }
    ],
    "seo": {
        "meta_title": "Pulse Biosciences, Inc. | Innovative Medical Technology",
        "meta_description": "Explore Pulse Biosciences, Inc., a leader in medical technology focused on developing the CellFX System for non-invasive treatment solutions. Discover our innovative approach to healthcare.",
        "keywords": [
            "Pulse Biosciences",
            "Nano-Pulse Stimulation",
            "Medical Technology",
            "CellFX System",
            "Healthcare Innovation"
        ]
    },
    "faq": [
        {
            "question": "What is the CellFX System?",
            "answer": "The CellFX System is a proprietary medical device that uses Nano-Pulse Stimulation technology to treat various dermatological conditions."
        },
        {
            "question": "Who is the CEO of Pulse Biosciences?",
            "answer": "Darrin Uecker is the CEO of Pulse Biosciences, Inc."
        },
        {
            "question": "Where is Pulse Biosciences headquartered?",
            "answer": "Pulse Biosciences is headquartered in Hayward, California, USA."
        },
        {
            "question": "What are the main applications of the CellFX System?",
            "answer": "The CellFX System is primarily used for treating skin lesions, sebaceous hyperplasia, and warts, with potential applications in oncology."
        },
        {
            "question": "When was Pulse Biosciences founded?",
            "answer": "Pulse Biosciences was founded in 2016."
        }
    ],
    "competitors": [
        "SYK",
        "BDX",
        "ISRG"
    ],
    "related_stocks": [
        "MDT",
        "ABT",
        "ZBH",
        "BSX"
    ]
}